Larimar Therapeutics Inc Shares Close the Day 11.1% Lower - Daily Wrap
The company saw its shares close the day 11.1% lower than yesterday, with trading volume higher than its 30 day average.
Apr 15, 2021 by Kwhen Finance Editors
Larimar Therapeutics Inc shares closed today 11.1% lower than it did at the end of yesterday. The stock is currently down 46.7% year-to-date, up 1412.2% over the past 12 months, and up 64.8% over the past five years. Today, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 1.1%.
Trading Activity
- Shares traded as high as $15.09 and as low as $11.38 this week.
- Shares closed 6e+1% below its 52-week high and 1e+3% above its 52-week low.
- Trading volume this week was 7.7% lower than the 10-day average and 36.5% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis
- The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Larimar Therapeutics Inc | -11.1 | -46.7 | 1412.2 | ||
| Dow Jones Industrial Average | 0.9 | 11.8 | 47.7 | -0.6 | 51.3 |
| S&P 500 Index | 1.1 | 11.6 | 52.1 | -0.6 | 54.6 |
| Health Care | 1.8 | 6.7 | 28.7 | -1.5 | 27.1 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -227.7%
- The company's stock price performance over the past 12 months beats the peer average by 1355.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Larimar Therapeutics Inc | LRMR | 0 | -46.7 | 1412.2 | ||
| Peer Avg | N/A | 0 | 36.5 | 97.0 | -16.0 | 25.7 |
| Ocular Therapeutix Inc | OCUL | 0 | -22.0 | 191.5 | ||
| OncoCyte Corp | OCX | 0 | 113.0 | 143.5 | ||
| Oragenics Inc. | OGEN | 0 | 55.1 | 53.1 | -64.1 | 102.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: